𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Modulation of CXCR3 ligand secretion by prostaglandin E2and cyclooxygenase inhibitors in human breast cancer

✍ Scribed by Holger Bronger; Sara Kraeft; Ulrike Schwarz-Boeger; Claudia Cerny; Alexandra Stöckel; Stefanie Avril; Marion Kiechle; Manfred Schmitt

Book ID
115028262
Publisher
BioMed Central
Year
2012
Tongue
English
Weight
633 KB
Volume
14
Category
Article
ISSN
1465-5411

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression of cyclooxygenase-2 and perox
Expression of cyclooxygenase-2 and peroxisome proliferator-activated receptor-γ and levels of prostaglandin E2 and 15-deoxy-Δ12,14-prostaglandin J2 in human breast cancer and metastasis
✍ Alaa F. Badawi; Mostafa Z. Badr 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 193 KB 👁 1 views

## Abstract Cyclooxygenase‐2 (COX‐2) expression and peroxisome proliferator‐activated receptor‐γ (PPARγ) inactivation are linked to increased risk of human breast cancer. The purpose of our study was to examine the relationship between COX‐2 (with the resulting prostaglandins E~2~, PGE~2~) and PPAR

ChemInform Abstract: Efficient Synthesis
ChemInform Abstract: Efficient Synthesis of Apricoxib, CS-706, a Selective Cyclooxygenase-2 Inhibitor, and Evaluation of Inhibition of Prostaglandin E2 Production in Inflammatory Breast Cancer Cells.
✍ Pijus K. Mandal; Eric M. Freiter; Allison L. Bagsby; Fredika M. Robertson; John 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 33 KB 👁 1 views

## Abstract A highly efficient synthesis of the promising Cox‐2 inhibitor, apricoxib (VI), in only three steps from commercially available starting material is given.